"10.1371_journal.pone.0007871","plos one","2009-11-17T00:00:00Z","Quique Bassat; Modest Mulenga; Halidou Tinto; Patrice Piola; Steffen Borrmann; Clara Menéndez; Michael Nambozi; Innocent Valéa; Carolyn Nabasumba; Philip Sasi; Antonella Bacchieri; Marco Corsi; David Ubben; Ambrose Talisuna; Umberto D'Alessandro","Barcelona Centre for International Health Research (CRESIB), Hospital Clínic, Institut dInvestigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain; Manhiça Health Research Centre (CISM), Manhiça, Mozambique; Tropical Disease Research Centre, Ndola, Zambia; Centre Muraz, Bobo-Dioulasso, Burkina Faso, IRSS/DRO, Bobo-Dioulasso, Burkina Faso; Epicentre/MSF, Mbarara, Uganda; Kenya Medical Research Institute, Kilifi, Kenya; University of Heidelberg, Heidelberg, Germany; Department of Clinical Pharmacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania; Sigma Tau Industrie Farmaceutiche Riunite, Pomezia, Rome, Italy; Medicines for Malaria Venture, Geneva, Switzerland; Prince Leopold Institute of Tropical Medicine, Antwerp, Belgium","none","David Ubben is an employee of Medicines for Malaria Venture. Ambrose Talisuna is now an employee of Medicines for Malaria Venture but at the time the study was conducted he was employed by the Institute of Tropical Medicine, Antwerp. Antonella Bacchieri and Marco Corsi are employees of Sigma-Tau. Umberto DAlessandro has received additional research funds from Sigma Tau. The study was supported by funds from the Medicines for Malaria Venture and sponsored by Sigma-Tau I.F.R. SpA (Rome). Employees of Sigma-Tau participated in study design, data entry, collection and analysis of data. Medicines for Malaria Venture employees contributed to the preparation of the manuscript. An author independent of the sponsor, Umberto DAlessandro, had access to the primary dataset and takes responsibility for the analyses and manuscript as a whole.","2009","11","Quique Bassat","QB",15,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
